A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies

Journal of Nuclear Cardiology

Volumn 14, Issue 2, 2007, Pages 215-220

  Matsuo, Shinro ^a   Nakae, Ichiro ^a   Tsutamoto, Takayoshi ^a   Okamoto, Noriake ^b   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

congestive heart failure; Technetium 99m sestamibi; washout rate

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PRIORITY JOURNAL; SCINTIGRAPHY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARDIOMYOPATHIES; COMPUTER SIMULATION; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MITOCHONDRIA, HEART; MODELS, CARDIOVASCULAR; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 33947384177     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.10.022     Document Type: Article

References (29)

1. Piwnica-Worms D., Kronauge J.F., and Chiu M.L. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (1) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 82 (1990) 1826-1838
2. Chiu M.L., Kronauge J.F., and Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutyl isonitrile) technetium(1) in cultured mouse fibroblasts. J Nucl Med 31 (1990) 1646-1653
3. Delmon-Moingeon L.I., Piwnica-Worms D., Van den Abbeele A.D., Holman B.L., Davison A., and Jones A.G. Uptake of the cation hexakis (2-methoxyisobutyl isonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50 (1990) 2198-2202
4. Piwnica-Worms D., Chiu M.L., and Kronauge J.F. Divergent kinetics of Tl-201 and Tc-99m sestamibi in cultured chick ventricular myocytes during ATP depletion. Circulation 85 (1992) 1531-1541
5. Carvalho P.A., Chiu M.L., Kronauge J.F., Kawamura M., Jones A.G., Holman B.L., et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33 (1992) 1516-1521
6. Crane P., Laliberte R., Heminway S., Thoolen M., and Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 20 (1993) 20-25
7. Okada R., Glover D., Gaffney T., and Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77 (1988) 491-498
8. Li Q.-S., Frank T.L., Franceschi D., Wagner H.N., and Becker L.C. Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med 29 (1988) 1539-1548
9. Wackers F.J., Berman D.S., Maddahi J., Watson D.D., Beller G.A., Strauss H.W., et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30 (1989) 301-311
10. Beller G., and Watson D. Physiological basis of myocardial perfusion imaging with the technetium-99m agents. Semin Nucl Med 21 (1991) 173-181
11. Takeishi Y., Sukegawa H., Fujiwara S., Ikeno E., Sasaki Y., and Tomoike H. Reverse redistribution of technetium-99m sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 37 (1996) 1289-1294
12. Fujiwara S., Takeishi Y., Atsumi H., Yamaki M., Takahashi N., Yamaoka M., et al. Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch. J Nucl Cardiol 5 (1998) 119-127
13. Fujiwara S., Takeishi Y., Hirono O., Fukui A., Okuyama M., Yamaguchi S., et al. Reverse redistribution of Tc-99m sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: relationship with wall motion and functional response to dobutamine stimulation. Nucl Med Commun 22 (2001) 1223-1230
14. Kumita S., Seino Y., Cho K., Nakajo H., Toba M., Fukushima Y., et al. Assessment of myocardial washout of Tc-99m-sestamibi in patients with chronic heart failure: comparison with normal control. Ann Nucl Med 4 (2002) 237-242
15. Sugiura T., Takase H., Toriyama T., Goto T., Ueda R., and Dohi Y. Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure. J Nucl Cardiol 13 (2006) 64-68
16. Liu Z., Jonson G., Beju D., and Okada R.O. Detection of myocardial viability in ischemic reperfused rat hearts by Tc-99m sestamibi kinetics. J Nucl Cardiol 8 (2001) 677-686
17. Nakae I., Matsuo S., Koh T., Mitsunami K., and Horie M. Left ventricular systolic/diastolic function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography and plasma BNP analysis. Ann Nucl Med 19 (2005) 447-454
18. Matsuo S., Nakae I., Matsumoto T., and Horie M. Impact of endothelial dysfunction on left ventricular remodeling after successful primary coronary angioplasty for acute myocardial infarction-analysis by quantitative ECG-gated SPECT. Ann Nucl Med 20 (2006) 57-62
19. Germano G., Kiat H., Kavanagh P.B., Moriel M., Mazzanti M., Su H.T., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
20. Matsuo S., Takahashi M., Nakamura Y., and Kinoshita M. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. J Nucl Med 37 (1996) 712-717
21. Matsuo S., Nakamura Y., Takahashi M., Matsui T., Kusukawa J., Yoshida S., et al. Cardiac sympathetic dysfunction in athlete's heart detected by 123I MIBG scintigraphy. Jpn Circ J 65 (2001) 371-374
22. Matsuo S., Nakamura Y., Matsui T., Matsumoto T., and Kinoshita M. Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging. Ann Nucl Med 15 (2001) 373-375
23. Matsuo S., Nakamura Y., Tsutamoto T., and Kinoshita M. Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy. J Nucl Cardiol 9 (2002) 407-412
24. Yamada T., Shimonagata T., Fukunami M., Kumagai K., Ogita H., Hirata A., et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol 41 (2003) 231-238
25. Piwnica-Worms D., Chiu M.L., Budding M., Kronauge J.F., Kramer R.A., and Croop J.M. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53 (1993) 977-984
26. Luker G.D., Rao V.V., Crankshaw C.L., Dahlheimer J., and Piwnica-Worms D. Characterization of phoshine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Biochemistry 36 (1997) 14218-14227
27. Arbustini E., Diegoli M., Fasani R., Grasso M., Morbini P., Banchieri N., et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 153 (1998) 1501-1510
28. Ruppert V., and Maisch B. Mitochondrial DNA deletions in cardiomyopathies. Herz 25 (2000) 161-167
29. Suematsu N., Tsutsui H., Wen J., Kang D., Ikeuchi M., Ide T., et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107 (2003) 1418-1423